Systematic Multi-Domain Alzheimer’s Risk Reduction Trial (SMARRT): Study Protocol

Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics: The FINGER trial

(2018) Anna Rosenberg et al.   Alzheimers & Dementia

Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease

(2018) Alireza Atri et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease

(2018) Lawrence S. Honig et al.   NEW ENGLAND JOURNAL OF MEDICINE

Modifiable Risk Factors and Prevention of Dementia

(2018) Kristine Yaffe   JAMA Internal Medicine

Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial

(2017) Sandrine Andrieu et al.   LANCET NEUROLOGY

The changing prevalence and incidence of dementia over time — current evidence

(2017) Yu-Tzu Wu et al.   Nature Reviews Neurology

Practice guideline update summary: Mild cognitive impairment

(2017) Ronald C. Petersen et al.   NEUROLOGY

A Comparison of the Prevalence of Dementia in the United States in 2000 and 2012

(2017) Kenneth M. Langa et al.   JAMA Internal Medicine

The PROMIS satisfaction with social participation measures demonstrated responsiveness in diverse clinical populations

(2016) Elizabeth A. Hahn et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial

(2016) Eric P Moll van Charante et al.   LANCET

MIND diet associated with reduced incidence of Alzheimer's disease

(2015) Martha Clare Morris et al.   Alzheimers & Dementia

MIND diet slows cognitive decline with aging

(2015) Martha Clare Morris et al.   Alzheimers & Dementia

American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

(2015)   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial

(2015) Tiia Ngandu et al.   LANCET

Tracking Early Decline in Cognitive Function in Older Individuals at Risk for Alzheimer Disease Dementia

(2015) Rebecca E. Amariglio et al.   JAMA Neurology

Would Older Adults with Mild Cognitive Impairment Adhere to and Benefit from a Structured Lifestyle Activity Intervention to Enhance Cognition?: A Cluster Randomized Controlled Trial

(2015) Linda Chiu-wa Lam et al.   PLoS One

Cognition in MCI and Alzheimer’s Disease: Baseline Data from a Longitudinal Study of the NTB

(2014) John Harrison et al.   CLINICAL NEUROPSYCHOLOGIST

Potential for primary prevention of Alzheimer's disease: an analysis of population-based data

(2014) Sam Norton et al.   LANCET NEUROLOGY

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

(2014) Stephen Salloway et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of a Multidomain Lifestyle Modification on Cognitive Function in Older Adults: An Eighteen-Month Community-Based Cluster Randomized Controlled Trial

(2014) Kang Soo Lee et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Alzheimer’s disease drug-development pipeline: few candidates, frequent failures

(2014) Jeffrey L Cummings et al.   Alzheimers Research & Therapy

Reduction of Inappropriate Benzodiazepine Prescriptions Among Older Adults Through Direct Patient Education

(2014) Cara Tannenbaum et al.   JAMA Internal Medicine

Association of Lifetime Intellectual Enrichment With Cognitive Decline in the Older Population

(2014) Prashanthi Vemuri et al.   JAMA Neurology

The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): Study design and progress

(2013) Miia Kivipelto et al.   Alzheimers & Dementia

A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II

(2013) Fiona E Matthews et al.   LANCET

Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden

(2013) C. Qiu et al.   NEUROLOGY

New Insights into the Dementia Epidemic

(2013) Eric B. Larson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study

(2012) E. M. C. Schrijvers et al.   NEUROLOGY

Trends in the incidence and prevalence of Alzheimer’s disease, dementia, and cognitive impairment in the United States

(2011) Walter A. Rocca et al.   Alzheimers & Dementia

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Reisa A. Sperling et al.   Alzheimers & Dementia

The projected effect of risk factor reduction on Alzheimer's disease prevalence

(2011) Deborah E Barnes et al.   LANCET NEUROLOGY

Dementia incidence continues to increase with age in the oldest old: The 90+ study

(2009) María M. Corrada et al.   ANNALS OF NEUROLOGY

Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items

(2009) Ron D. Hays et al.   QUALITY OF LIFE RESEARCH

The PHQ-8 as a measure of current depression in the general population

(2008) Kurt Kroenke et al.   JOURNAL OF AFFECTIVE DISORDERS